An HIV-infected patient with no serious adverse events after overdosing on raltegravir

Tomohiro Hosoda, Yuki Uehara, Toshio Naito

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Patients with HIV infection represent a high-risk group for medication overdose because of the high frequency of complicating psychiatric disorders. Raltegravir is well-known for its low frequency of adverse effects. We herein report a 42-year-old Japanese man with HIV infection who was hospitalized 6 hours after overdosing with 24,000 mg of raltegravir in a suicide attempt. No serious adverse events occurred, although the plasma concentration of raltegravir at 18 hours after the overdose was 79,871.1 ng/mL. Raltegravir may be well-indicated for HIV patients at risk of overdosing.

Original languageEnglish
Pages (from-to)285-287
Number of pages3
JournalInternal Medicine
Volume59
Issue number2
DOIs
Publication statusPublished - 15-01-2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Fingerprint

Dive into the research topics of 'An HIV-infected patient with no serious adverse events after overdosing on raltegravir'. Together they form a unique fingerprint.

Cite this